BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8565109)

  • 1. [Some new advances in the study on p53].
    Zhou Q; Yang G
    Zhonghua Bing Li Xue Za Zhi; 1995 Aug; 24(4):267-8. PubMed ID: 8565109
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53: it has it all, but will it make it to the clinic as a marker in bladder cancer?
    Real FX
    J Clin Oncol; 2007 Dec; 25(34):5341-4. PubMed ID: 18048811
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
    Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
    Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells.
    Corbet SW; Clarke AR; Gledhill S; Wyllie AH
    Oncogene; 1999 Feb; 18(8):1537-44. PubMed ID: 10102623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of p53 gene mutation and P53 protein expression abnormality on the prognosis of esophageal cancer: a meta-analysis study].
    Wang XL; Zhang CM; Shi LY; Yu HP; Xu SQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):769-74. PubMed ID: 15555357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitivity in lung cancer with focus on p53: a review based on a doctoral thesis.
    Bergqvist M
    Ups J Med Sci; 2003; 108(2):87-127. PubMed ID: 14649323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Expression of mutant P53 gene protein product in human bladder carcinoma].
    Ye DW
    Zhonghua Wai Ke Za Zhi; 1993 Aug; 31(8):484-6. PubMed ID: 8112175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma.
    Chen TC; Hsieh LL; Kuo TT
    J Pathol; 1995 Jul; 176(3):243-7. PubMed ID: 7674087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene.
    Dudgeon C; Kek C; Demidov ON; Saito S; Fernandes K; Diot A; Bourdon JC; Lane DP; Appella E; Fornace AJ; Bulavin DV
    Cancer Res; 2006 Mar; 66(6):2928-36. PubMed ID: 16540640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p53 tumor suppressor gene and Fas/Apo-1 in induction of apoptosis and differentiation of cancer cells.
    Takahashi R
    Leukemia; 1997 Apr; 11 Suppl 3():331-3. PubMed ID: 9209381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of phosphoprotein P53 in pathology].
    Casazza S
    Pathologica; 1993; 85(1097):321-34. PubMed ID: 8233649
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
    Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on p53 gene mutation, protein expression and relationship with clinico-pathological status in large cell carcinoma of the lung].
    Meng Y; Li W; Da J
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):212-5. PubMed ID: 9275654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis by p53, bax, bcl-2, and p21 expressed in colorectal cancer.
    Katsumata K; Sumi T; Tomioka H; Aoki T; Koyanagi Y
    Int J Clin Oncol; 2003 Dec; 8(6):352-6. PubMed ID: 14663636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S; Chapman W; McLaughlin J; Andrulis IL
    Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of p53 in nephroblastoma and neuroblastoma].
    Bu X; Shen Z; Jin B
    Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):220-2. PubMed ID: 10374542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on p53 gene expression following transient ischemia in the gerbil].
    Gu WP; Yang QD; Xie GJ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):121-2. PubMed ID: 12536640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-P53/K562 from apoptosis.
    Magnelli L; Cinelli M; Chiarugi V
    Biochem Biophys Res Commun; 1995 Oct; 215(2):641-5. PubMed ID: 7488003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.